Home / Medical Devices / In-Vitro Diagnostics Quality Control Market By Product (Quality Controls, Data Management Solutions, Quality Assurance Services), By Application (Immunochemistry, Clinical Chemistry, Hematology, Coagulation, Molecular Diagnostics, Microbiology, Others) - Growth, Future Prospects, Competitive Analysis, 2018 - 2026

In-Vitro Diagnostics Quality Control Market By Product (Quality Controls, Data Management Solutions, Quality Assurance Services), By Application (Immunochemistry, Clinical Chemistry, Hematology, Coagulation, Molecular Diagnostics, Microbiology, Others) - Growth, Future Prospects, Competitive Analysis, 2018 - 2026

Published: Mar 2019 | Report Code: 59637-03-19

Industry Outlook

The global in-vitro diagnostics quality control market was valued at US$ 854.0 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 3.9% during the forecast period from 2018 to 2026. In-vitro diagnostics quality control are tests to validate the efficacy and reliability of the in-vitro diagnostic systems and ensure its accuracy and evaluate the impact of environmental conditions and other things that can affect the test results. Erroneous in-vitro diagnostic testing systems have significant side-effects on the patients. Moreover, it can delay in diagnosis and may also result in improper treatment leading to long-term complications and additional healthcare cost. Moreover, failure to identify the pathogen especially during an outbreak can delay in determining the true cause and thereby lead to inaccurate measures for the same. Poor diagnostic quality also leads to poor patient outcomes, increased mortality and morbidity posing a barrier in public health interventions. Growing usage of in-vitro diagnostic testing for various diseases such as infectious diseases, cardiovascular disorders and oncology testing is the major driver for the growth of in-vitro diagnostics quality control market. Moreover, growing inclination towards personalized medicine and molecular diagnostic to explore knowledge and treatment for rare diseases are boosting use of in-vitro diagnostics, thereby growing the market for in-vitro diagnostics quality control market. 

Get a sample copy for more information

Market Synopsis

In-Vitro Diagnostics Quality Control Market

Get a sample copy for more information

Quality Controls Segment Accounted for the Largest Share by Product Type  

The in-vitro diagnostics quality control market is segmented in to quality controls, data management solutions, and quality assurance services. In 2017, quality controls segment held the largest share in the market owing to high demand of these products for validating the accuracy and precision of the in-vitro diagnostic tests. Quality control is an important aspect in the clinical and laboratory based testing to ensure safety and accuracy as per standards set by Food and Drug Administration (FDA), European Communities Confederation of Clinical Chemistry and Laboratory Medicine (EC4) and Clinical Laboratory Improvement Amendments (CLIA).

In-Vitro Diagnostics Quality Control Market

Get a sample copy for more information

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

In-vitro diagnostics quality control market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on product type, applications and geography.

ATTRIBUTE DETAILS
Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million
Segmentation

 By Product (2016–2026; US$ Mn)
 • Quality Controls
    o Whole Blood-Based Controls
    o Serum/plasma-based Controls
    o Urine-based controls
    o Others
 • Data Management Solutions
 • Quality Assurance Services

 By Application (2016–2026; US$ Mn)
 • Immunochemistry
 • Clinical Chemistry
 • Hematology
 • Coagulation
 • Molecular Diagnostics
 • Microbiology
 • Others

 Geography Segment (2016–2026; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of APAC)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of Middle East and Africa)

The in-vitro diagnostics quality control market is studied to understand the current and future trends and dynamics. The study scope includes market size and forecast for all considered segments studied in the report for the period from 2016 to 2026, along with compound annual growth rate (CAGR) for forecast period from 2018 to 2026, 2017 being the considered as the base year. The key players currently engaged in In-vitro diagnostics quality control market include Siemens Healthineers, Thermo Fisher Scientific, Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Seracare Life Sciences, Inc., Sysmex Corporation, Helena Laboratories, Sun Diagnostics, LLC among others. 


In-Vitro Diagnostics Quality Control Market

Get a sample copy for more information

Key questions answered in this report

  • How the global in-vitro diagnostics quality control market will perform during the forecast period from 2018 to 2026?
  • What are the latest trends in the in-vitro diagnostics quality control market and valuable opportunities for key players?
  • Who are the leading players in the global in-vitro diagnostics quality control market?
  • Which is the leading and fastest region in the global in-vitro diagnostics quality control market?
  • What are drivers and restrains governing the global in-vitro diagnostics quality control market? 

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global IVDQC Market Portraiture
2.2. Global IVDQC Market, by Product Type, 2017 (US$ Mn)
2.3. Global IVDQC Market, by Application, 2017 (US$ Mn)
2.4. Global IVDQC Market, by Geography, 2017 (US$ Mn)

Chapter 3. In-Vitro Diagnostics Quality Control (IVDQC): Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global IVDQC Market, by Key Players, 2017

Chapter 4. Global In-Vitro Diagnostics Quality Control (IVDQC) Market, by Product Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Quality Controls
4.2.1. Whole Blood-Based Controls
4.2.2. Serum/plasma-based Controls
4.2.3. Urine-based controls
4.2.4. Others
4.3. Data Management Solutions
4.4. Quality Assurance Services

Chapter 5. Global In-Vitro Diagnostics Quality Control (IVDQC) Market, by Application, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Immunochemistry
5.3. Clinical Chemistry
5.4. Hematology
5.5. Coagulation
5.6. Molecular Diagnostics
5.7. Microbiology
5.8. Others

Chapter 6. Global In-Vitro Diagnostics Quality Control (IVDQC) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America IVDQC Market Analysis, 2016 – 2026
6.1.1. North America IVDQC Market, by Product Type, 2016 - 2026 (US$ Mn)
6.1.2. North America IVDQC Market, by Application, 2016 - 2026 (US$ Mn)
6.1.3. North America IVDQC Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. U.S.
6.1.3.2. Canada
6.2. Europe IVDQC Market Analysis, 2016 – 2026
6.2.1. Europe IVDQC Market, by Product Type, 2016 - 2026 (US$ Mn)
6.2.2. Europe IVDQC Market, by Application, 2016 - 2026 (US$ Mn)
6.2.3. Europe IVDQC Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific IVDQC Market Analysis, 2016 – 2026
6.3.1. Asia Pacific IVDQC Market, by Product Type, 2016 - 2026 (US$ Mn)
6.3.2. Asia Pacific IVDQC Market, by Application, 2016 - 2026 (US$ Mn)
6.3.3. Asia Pacific IVDQC Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. Rest of Asia Pacific
6.4. Latin America IVDQC Market Analysis, 2016 – 2026
6.4.1. Latin America IVDQC Market, by Product Type, 2016 - 2026 (US$ Mn)
6.4.2. Latin America IVDQC Market, by Application, 2016 - 2026 (US$ Mn)
6.4.3. Latin America IVDQC Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa IVDQC Market, 2016 – 2026
6.5.1. Middle East & Africa IVDQC Market, by Product Type, 2016 - 2026 (US$ Mn)
6.5.2. Middle East & Africa IVDQC Market, by Application, 2016 - 2026 (US$ Mn)
6.5.3. Middle East & Africa IVDQC Market, by Region, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa

Chapter 7. Company Profiles
7.1. Abbott Laboratories Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Bio-Rad Laboratories, Inc.
7.3. Helena Laboratories
7.4. Ortho Clinical Diagnostics, Inc.
7.5. Randox Laboratories Ltd.
7.6. Roche Diagnostics
7.7. Seracare Life Sciences, Inc.
7.8. Siemens Healthineers
7.9. Sun Diagnostics, LLC
7.10. Thermo Fisher Scientific Inc.
7.11. Sysmex Corporation
7.12. Quantimetrix Corporation

Note: Modification in the list of company profiles or scope of the study can be incorporated on request.

* IVDQC - In-Vitro Diagnostics Quality Control 

FIG 1: In-Vitro Diagnostics Quality Controls (IVDQC) Market: Research Methodology
FIG 2: IVDQC: Market Segmentation
FIG 3: Global IVDQC Market, by Product Type, 2017 (US$ Mn)
FIG 4: Global IVDQC Market, by Application, 2017 (US$ Mn)
FIG 5: Global IVDQC Market, by Geography, 2017 (US$ Mn)
FIG 6: Attractive Investment Proposition, by Geography, 2017
FIG 7: Competitive Analysis: Global IVDQC Market, by Key Players, 2017
FIG 8: Global IVDQC Market, 2016-2026 (US$ Mn)
FIG 9: Global Whole Blood-Based Controls in IVDQC Market, 2016-2026 (US$ Mn)
FIG 10: Global Serum/plasma-based Controls in IVDQC Market, 2016-2026 (US$ Mn)
FIG 11: Global Urine-based controls in IVDQC Market, 2016-2026 (US$ Mn)
FIG 12: Global Other IVD Quality Controls in IVDQC Market, 2016-2026 (US$ Mn)
FIG 13: Global Data Management Solutions in IVDQC Market, 2016-2026 (US$ Mn), 2016-2026 (US$ Mn)
FIG 14: Global Quality Assurance Services in IVDQC Market, 2016-2026 (US$ Mn)
FIG 15: Global Immunochemistry Application in IVDQC Market, 2016-2026 (US$ Mn)
FIG 16: Global Clinical Chemistry Application in IVDQC Market, 2016-2026 (US$ Mn)
FIG 17: Global Hematology Application in IVDQC Market, 2016-2026 (US$ Mn)
FIG 18: Global Hematology Application in IVDQC Market, 2016-2026 (US$ Mn)
FIG 19: Global Coagulation Application in IVDQC Market, 2016-2026 (US$ Mn)
FIG 20: Global Molecular Diagnostics Application in IVDQC Market, 2016-2026 (US$ Mn)
FIG 21: Global Microbiology Application in IVDQC Market, 2016-2026 (US$ Mn)
FIG 22: Global Other Applications in IVDQC Market, 2016-2026 (US$ Mn)
FIG 23: U.S. IVDQC Market, 2016-2026 (US$ Mn)
FIG 24: Canada IVDQC Market, 2016-2026 (US$ Mn)
FIG 25: U.K. IVDQC Market, 2016-2026 (US$ Mn)
FIG 26: Germany IVDQC Market, 2016-2026 (US$ Mn)
FIG 27: Rest of Europe IVDQC Market, 2016-2026 (US$ Mn)
FIG 28: China IVDQC Market, 2016-2026 (US$ Mn)
FIG 29: Japan IVDQC Market, 2016-2026 (US$ Mn)
FIG 30: Rest of Asia Pacific IVDQC Market, 2016-2026 (US$ Mn)
FIG 31: Brazil IVDQC Market, 2016-2026 (US$ Mn)
FIG 32: Mexico IVDQC Market, 2016-2026 (US$ Mn)
FIG 33: Rest of Latin America IVDQC Market, 2016-2026 (US$ Mn)
FIG 34: GCC IVDQC Market, 2016-2026 (US$ Mn)
FIG 35: Rest of Middle East & Africa IVDQC Market, 2016-2026 (US$ Mn)

TABLE 1 : Global In-Vitro Diagnostics Quality Controls (IVDQC) Market Portraiture
TABLE 2 : Global IVDQC Market, by Product Type, 2016-2026 (US$ Mn)
TABLE 3 : Global Quality Controls in In-Vitro Diagnostics Quality Control Market,2016-2026 (US$ Mn)
TABLE 4 : Global IVDQC Market, by Application, 2016 - 2026 (US$ Mn)
TABLE 5 : Global IVDQC Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 : North America In-Vitro Diagnostics Quality Control Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 7 : North America In-Vitro Diagnostics Quality Control Market, by Application, 2016 - 2026 (US$ Mn)
TABLE 8 : North America In-Vitro Diagnostics Quality Control Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 9 : Europe In-Vitro Diagnostics Quality Control Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 10 : Europe In-Vitro Diagnostics Quality Control Market, by Application, 2016 - 2026 (US$ Mn)
TABLE 11 : Europe In-Vitro Diagnostics Quality Control Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 : Asia Pacific In-Vitro Diagnostics Quality Control Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 13 : Asia Pacific In-Vitro Diagnostics Quality Control Market, by Application, 2016 - 2026 (US$ Mn)
TABLE 14 : Asia Pacific In-Vitro Diagnostics Quality Control Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 : Latin America In-Vitro Diagnostics Quality Control Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 16 : Latin America In-Vitro Diagnostics Quality Control Market, by Application, 2016 - 2026 (US$ Mn)
TABLE 17 : Latin America In-Vitro Diagnostics Quality Control Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18 : Middle East & Africa In-Vitro Diagnostics Quality Control Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 19 : Middle East & Africa In-Vitro Diagnostics Quality Control Market, by Application, 2016 - 2026 (US$ Mn)
TABLE 20 : Middle East & Africa In-Vitro Diagnostics Quality Control Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 21 : Abbott Laboratories Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 : Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 : Helena Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 : Ortho Clinical Diagnostics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 : Randox Laboratories Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 : Roche Diagnostics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 : Seracare Life Sciences, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 : Siemens Healthineers: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 : Sun Diagnostics, LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 : Thermo Fisher Scientific Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 : Sysmex Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 : Quantimetrix Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Our Clients